Skip to main content
. 2011 Feb 11;6(2):e17163. doi: 10.1371/journal.pone.0017163

Table 1. Overview of the samples included in the study.

FF_array_ID FFPE_array_ID RIN (FF) PCR fragments (FFPE) IHC IHC/CISH
pair_ID FF_ID FFPE_ID a b c a b c a b a b ER PgR HER2 MP grade
1 24720 2790 1 2 87 3 4 92 9.8 9.5 4 4 100% 0% 3 High 3
2 24926 4021 5 6 - 9 10 - 8.2 9.3 4 4 0% 0% 3 High 3
3 25287 5887 11 12 - 13 14 - 8.8 9 4 4 100% 10% 1 Low 1
4 25217 5536 15 16 - 17 18 - 8.5 8.8 4 4 80% 10% 3 High 2
5 25194 5371 19 20 - 21 22 - 8.9 8.3 4 4 100% 100% 0 Low 2
6 25418 6635 23 24 88 25 26 93 9.2 7.9 4 4 80% 80% 0 Low 1
7 25972 9001 27 28 89 29 30 94 8.1 9 4 4 100% 100% 0 High 2
8 24386 1053 31 32 - 33 34 - 9.3 8.5 4 4 70% NA 1 High 3
9 24428 1221 35 36 - 37 38 - 9.6 9.3 4 4 100% 0% 3 High 2
10 24788 3264 41 42 - 43 44 - 8.9 8.9 4 4 0% 0% 1 High 3
11 24807 3428 45 46 90 47 48 95 9.2 9.1 4 4 75% 40% 0 High 3
12 25043 4732 49 50 - 51 52 - 7.4 8.3 4 4 1% 0% 3 High 3
13 25172 5290 53 54 - 55 56 - 8.6 8.2 4 4 100% 100% 3 High 2
14 25576 7296 57 58 - 59 60 - 7.9 8.2 4 4 100% 100% 0 Low 2
15 25468 6825 61 62 - 63 64 - 8.2 9.5 4 4 0% 0% 3 High 3
16 24266 0173 65 66 - 67 68 - 8.6 9.4 4 4 100% 80% 0 Low 1
17 24389 1070 69 70 91 73 74 96 8.9 9.5 4 4 100% 50% 1 High 2
18 25173 5292 75 76 - 77 78 - 7.9 7.6 4 4 100% 100% 1 Low 2
19 25298 5975 79 80 - 81 82 - 7.9 8.2 4 4 80% 0% 3 High 2
20 25575 7299 83 84 - 85 86 - 8 9.2 4 4 100% 60% 1 Low 1
21 25831 6473 not hybridized 4.9 5.9 4 4 0% 0% 3 NA 3

FF =  Fresh Frozen, FFPE =  Formalin Fixed Paraffin Embedded; pair_ID =  number of the pair FF-FFPE; FF (FFPE)_ID =  FF (FFPE) sample identifier; FF (FFPE)_array_ID =  sample identifier on the array; a, b =  biological replicates, c =  technical replicate; RIN =  RNA Integrity Number; ER =  Estrogen Receptor; PR =  Progesteron Receptor; HER2 =  Human Epidermal growth factor Receptor 2; IHC =  Immunohystochemistry; CISH =  Chromogenic In Situ Hybridization; MP =  MammaPrint, High =  high risk, Low =  low risk; grade =  histological grade; NA Not Available.